Vertex Pharmaceuticals, Inc. (VRTX)
542.62
-4.41
(-0.81%)
USD |
NASDAQ |
Nov 12, 16:00
545.00
+2.38
(+0.44%)
After-Hours: 04:02
Vertex Pharmaceuticals Market Cap : 137.57B for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 137.57B |
| November 11, 2026 | 138.68B |
| November 10, 2026 | 138.90B |
| November 09, 2026 | 139.66B |
| November 06, 2026 | 138.70B |
| November 05, 2026 | 137.54B |
| November 04, 2026 | 139.19B |
| November 03, 2026 | 134.56B |
| November 02, 2026 | 140.24B |
| October 30, 2026 | 141.69B |
| October 29, 2026 | 136.89B |
| October 28, 2026 | 134.20B |
| October 27, 2026 | 132.00B |
| October 26, 2026 | 131.10B |
| October 23, 2026 | 132.74B |
| October 22, 2026 | 135.58B |
| October 21, 2026 | 132.89B |
| October 20, 2026 | 130.39B |
| October 19, 2026 | 127.17B |
| October 16, 2026 | 126.61B |
| October 15, 2026 | 128.89B |
| October 14, 2026 | 126.29B |
| October 13, 2026 | 122.93B |
| October 12, 2026 | 128.45B |
| October 09, 2026 | 129.23B |
| Date | Value |
|---|---|
| October 08, 2026 | 127.50B |
| October 07, 2026 | 128.10B |
| October 06, 2026 | 127.26B |
| October 05, 2026 | 127.56B |
| October 02, 2026 | 127.87B |
| October 01, 2026 | 128.38B |
| September 30, 2026 | 132.45B |
| September 29, 2026 | 133.45B |
| September 28, 2026 | 133.68B |
| September 25, 2026 | 133.31B |
| September 24, 2026 | 132.34B |
| September 23, 2026 | 130.81B |
| September 22, 2026 | 130.47B |
| September 21, 2026 | 129.39B |
| September 18, 2026 | 128.79B |
| September 17, 2026 | 130.81B |
| September 16, 2026 | 130.03B |
| September 15, 2026 | 130.38B |
| September 14, 2026 | 131.62B |
| September 11, 2026 | 130.59B |
| September 10, 2026 | 130.36B |
| September 09, 2026 | 132.02B |
| September 08, 2026 | 134.00B |
| September 04, 2026 | 138.36B |
| September 03, 2026 | 141.36B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 20.97B |
| Gilead Sciences, Inc. | 208.43B |
| Regeneron Pharmaceuticals, Inc. | 98.35B |
| Sionna Therapeutics, Inc. | 155.09M |
| Amgen, Inc. | 252.63B |
Market Cap Related Metrics
| PE Ratio | 34.90 |
| PS Ratio | 10.65 |
| PEG Ratio | 3.650 |
| Price to Book Value | 6.580 |
| Price to Free Cash Flow | 43.33 |
| Price | 542.62 |
| Earnings Yield | 2.86% |
| PEGY Ratio | 3.650 |
| Operating PE Ratio | 30.49 |
| Normalized PE Ratio | 33.83 |